Reuters logo
BRIEF-U.S. FDA approves Vericel's Maci for repair of cartilage defects of knee in adult
December 14, 2016 / 5:20 AM / 9 months ago

BRIEF-U.S. FDA approves Vericel's Maci for repair of cartilage defects of knee in adult

Dec 14 (Reuters) - U.S. FDA:

* U.S. FDA approves first autologous cellularized scaffold for the repair of cartilage defects of the knee

* approved Maci for repair of symptomatic, full-thickness cartilage defects of knee in adult patients; Maci is manufactured by Vericel Corp

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below